详情页 - 河北医科大学第四医院机构库

资源类型：

文章类型：

作者：

Li, Jin[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] * ; Qin, Shukui[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Wen, Lu[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Wang, Junsheng[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Deng, Wenying[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Guo, Weijian[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Jia, Tongfu[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Jiang, Da[8]

; Zhang, Guifang[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; He, Yifu[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Zhong, Haijun[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Ba, Yi[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Lin, Xiaoyan[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Yang, Jianwei[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Zhao, Jun[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Bai, Yuxian[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Wu, Xiangyuan[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Gao, Feng[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Sun, Ying[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ; Hou, Zhiguo[1,2,3,4,5,6,7,9,10,11,12,13,14,15,16,17,18,19] ;

机构： [1]Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China [2]PLA Cancer Centre of Nanjing, Jinling Hospital, Nanjing, China [3]Department of Gastroenterology, Shanxi Provincial Cancer Hospital, Taiyuan, China [4]Department of Internal Medicine, Anyang Cancer Hospital, Anyang, China [5]Department of Gastroenterology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China [6]Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China [7]Department of Oncology, ZiBo Central Hospital, Zibo, China [8]Department of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China [9]Department of Oncology, Xinxiang Central Hospital, Xinxiang, China [10]Department of Oncology, The First Affiliated Hospital of USTC West District& Anhui Provicial Cancer Hospital, Hefei, China [11]Department of Medical Oncology, Zhejiang Cancer Hospital, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China [12]Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China [13]Department of Medical Oncology, Fujian Medical University Affiliated Union Hospital, Fuzhou, China [14]Department of Abdominal Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China [15]Department of Oncology, Changzhi People's Hospital, Changzhi, China [16]Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, China [17]Department of Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China [18]Department of Oncology, Heilongjiang Agricultural Reclamation Bureau General Hospital, Harbin, China [19]Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China

出处：

DOI：

ISSN：

基金：

语种：

WOS：

中科院分区：

出版当年[2021]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China [2]PLA Cancer Centre of Nanjing, Jinling Hospital, Nanjing, China [3]Department of Gastroenterology, Shanxi Provincial Cancer Hospital, Taiyuan, China [4]Department of Internal Medicine, Anyang Cancer Hospital, Anyang, China [5]Department of Gastroenterology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China [6]Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China [7]Department of Oncology, ZiBo Central Hospital, Zibo, China [9]Department of Oncology, Xinxiang Central Hospital, Xinxiang, China [10]Department of Oncology, The First Affiliated Hospital of USTC West District& Anhui Provicial Cancer Hospital, Hefei, China [11]Department of Medical Oncology, Zhejiang Cancer Hospital, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China [12]Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China [13]Department of Medical Oncology, Fujian Medical University Affiliated Union Hospital, Fuzhou, China [14]Department of Abdominal Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China [15]Department of Oncology, Changzhi People's Hospital, Changzhi, China [16]Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, China [17]Department of Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China [18]Department of Oncology, Heilongjiang Agricultural Reclamation Bureau General Hospital, Harbin, China [19]Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.

文献详情